References
- Y. Vinik, H. Shatz-Azoulay and Y. Zick, Molecular mechanisms underlying the role of galectin-8 as a regulator of cancer growth and metastasis, Trends Glycosci. Glycotechnol. 30(172) (2018) SE119– SE128; https://doi.org/10.4052/tigg.1742.1SE
- Y. R. Hadari, K. Paz, R. Dekel, T. Mestrovic, D. Accili and Y. Zick, Galectin-8: A new rat lectin, re-lated to galectin-4, J. Biol. Chem. 270(7) (1995) 3447–3453; https://doi.org/10.1074/jbc.270.7.3447
- Y. R. Hadari, R. Arbel-Goren, Y. Levy, A. Amsterdam, R. Alon, R. Zakut and Y. Zick, Galectin-8 binding to integrins inhibits cell adhesion and induces apoptosis, J. Cell Sci. 113(13) (2000) 2385–2397; https://doi.org/10.1242/jcs.113.13.2385
- R. V. Gopalkrishnan, T. Roberts, S. Tuli, D. C. Kang, K. A. Christiansen and P. B. Fisher, Molecular characterization of prostate carcinoma tumor antigen-1, PCTA-1, a human galectin-8 related gene, Oncogene 19(38) (2000) 4405–4416; https://doi.org/10.1038/sj.onc.1203767
- R. D. Cummings, F.-T. Liu, G. A. Rabinovich, S. R. Stowell and G. R. Vasta, Galectins, in Carbohydrates in Chemistry and Biology 4–4, Wiley Online Library, 2022, pp. 625–647; https://doi.org/10.1002/9783527618255
- E. Purić, U. J. Nilsson and M. Anderluh, Galectin-8 inhibition and functions in immune response and tumor biology, Med. Res. Rev. 44(5) (2024) 2236–2265; https://doi.org/10.1002/med.22041
- P. Sörme, B. Kahl-Knutson, U. Wellmar, U. J. Nilsson and H. Leffler, Fluorescence polarization to study galectin-ligand interactions, Methods Enzymol. 362 (2003) 504–512; https://doi.org/10.1016/S0076-6879(03)01033-4
- P. Sörme, B. Kahl-Knutson, M. Huflejt, U. J. Nilsson and H. Leffler, Fluorescence polarization as an analytical tool to evaluate galectin-ligand interactions, Anal. Biochem. 334 (2004) 36–47; https://doi.org/10.1016/j.ab.2004.06.042
- S. Carlsson, C. T. Öberg, M. C. Carlsson, A. Sundin, U. J. Nilsson, D. Smith, R. D. Cummings, J. Almkvist, A. Karlsson and H. Leffler, Affinity of galectin-8 and its carbohydrate recognition do-mains for ligands in solution and at the cell surface, Glycobiology 17(6) (2007) 663–676; https://doi.org/10.1093/glycob/CWM026
- C. T. Öberg, S. Carlsson, E. Fillion, H. Leffler and U. J. Nilsson, Efficient and expedient two-step pyranose-retaining fluorescein conjugation of complex reducing oligosaccharides: Galectin oligo-saccharide specificity studies in a fluorescence polarization assay, Bioconjug. Chem. 14(6) (2003) 1289–1297; https://doi.org/10.1021/bc034130J
- W. A. Lea and A. Simeonov, Fluorescence polarization assays in small molecule screening, Expert Opin. Drug Discov. 6(1) (2011) 17–32; https://doi.org/10.1517/17460441.2011.537322
- M. D. Hall, A. Yasgar, T. Peryea, J. C. Braisted, A. Jadhav, A. Simeonov and N. P. Coussens, Fluores-cence polarization assays in high-throughput screening and drug discovery: A review, Methods Appl. Fluoresc. 4(2) (2016) Article ID 022001; https://doi.org/10.1088/2050-6120/4/2/022001
- E. A. Howe, A. De Souza, D. L. Lahr, S. Chatwin, P. Montgomery, B. R. Alexander, D. T. Nguyen, Y. Cruz, D. A. Stonich, G. Walzer, J. T. Rose, S. C. Picard, Z. Liu, J. N. Rose, X. Xiang, J. Asiedu, D. Dur-kin, J. Levine, J. J. Yang, S. C. Schürer, J. C. Braisted, N. Southall, M. R. Southern, T. D. Y. Chung, S. Brudz, C. Tanega, S. L. Schreiber, J. A. Bittker, R. Guha and P. A. Clemons, BioAssay Research Data-base (BARD): chemical biology and probe-development enabled by structured metadata and result types, Nucleic Acids Res. 43 (2015) D1163–D1170; https://doi.org/10.1093/nar/gku1244
- E. Purić, M. Hassan, F. Sjövall, T. Tomašič, M. Pevec, J. Lah, J. A. Forteza, A. Sundin, H. Leffler, U. J. Nilsson, D. T. Logan and M. Anderluh, Nanomolar inhibitor of the galectin-8 N-terminal domain binds via a non-canonical cation-π interaction, Commun. Chem. 8(1) (2025) Article ID 59 (11 pages); https://doi.org/10.1038/s42004-025-01458-6
- K. B. Pal, M. Mahanti, X. Huang, S. Persson, A. P. Sundin, F. R. Zetterberg, S. Oredsson, H. Leffler and U. J. Nilsson, Quinoline-galactose hybrids bind selectively with high affinity to a galectin-8 N-terminal domain, Org. Biomol. Chem. 16(34) (2018) 6295–6305; https://doi.org/10.1039/C8OB01354C
- M. Hassan, S. van Klaveren, M. Håkansson, C. Diehl, R. Kovačič, F. Baussière, A. P. Sundin, J. Dernovšek, B. Walse, F. Zetterberg, H. Leffler, M. Anderluh, T. Tomašič, Ž. Jakopin and U. J. Nilsson, Benzimidazole-galactosides bind selectively to the galectin-8 N-terminal domain: Structure-based design and optimisation, Eur. J. Med. Chem. 223 (2021) Article ID 113664 (13 pages); https://doi.org/10.1016/j.ejmech.2021.113664
- M. Hassan, F. Baussière, S. Guzelj, A. P. Sundin, M. Håkansson, R. Kovačič, H. Leffler, T. Tomašič, M. Anderluh, Ž. Jakopin and U. J. Nilsson, Structure-guided design of d -galactal derivatives with high affinity and selectivity for the galectin-8 N-terminal domain, ACS Med. Chem. Lett. 12(11) (2021) 1745–1752; https://doi.org/10.1021/acsmedchemlett.1c00371
- B. Girardi, M. Manna, S. Van Klaveren, T. Tomašič, Ž. Jakopin, H. Leffler, U. J. Nilsson, D. Ricklin, J. Mravljak, O. Schwardt and M. Anderluh, Selective monovalent galectin-8 ligands based on 3-lact-oylgalactoside, ChemMedChem 17(3) (2022) Article ID e202100514; https://doi.org/10.1002/cmdc.202100514
- K. M. Craft and S. D. Townsend, Synthesis of lacto-N-tetraose, Carbohydr. Res. 440–441 (2017) 43–50; https://doi.org/10.1016/j.carres.2017.02.001
- J. H. Zhang, T. D. Y. Chung and K. R. Oldenburg, A simple statistical parameter for use in evaluation and validation of high throughput screening assays, SLAS Discovery 4(2) (1999) 67–73; https://doi.org/10.1177/108705719900400206